Abstract
摘要
相似文献
1
Salicylate kinetics and dosage rationale.
Med J Aust. 1972 Sep 23;2(13):696.
2
Salicylate accumulation kinetics in man.人体中水杨酸盐的蓄积动力学
N Engl J Med. 1972 Aug 31;287(9):430-2. doi: 10.1056/NEJM197208312870903.
3
Transport of salicylates from blood to joint fluid.
Arch Intern Med. 1973 Nov;132(5):668-72.
4
Plasma salicylate levels in rheumatoid arthritis produced by four different salicylate preparations.四种不同水杨酸盐制剂所产生的类风湿关节炎患者血浆水杨酸盐水平。
Med J Aust. 1970 Aug 22;2(8):382-3.
5
Plasma salicylate levels in rheumatoid arthritis produced by four different salicylate preparations.四种不同水杨酸盐制剂所产生的类风湿性关节炎患者的血浆水杨酸盐水平。
Med J Aust. 1970 Oct 3;2(14):653-4.
6
Salicylate pharmacokintics in the dog.犬体内水杨酸盐的药代动力学
Res Commun Chem Pathol Pharmacol. 1973 Jan;5(1):17-25.
7
Pharmacokinetics of salicylate in man.
Drug Metab Rev. 1979;9(1):3-19. doi: 10.3109/03602537909046431.
8
Plasma salicylate levels in rheumatoid arthritis produced by four different salicylate preparations.
Med J Aust. 1970 Jul 25;2(4):181-3.
9
[The presence of salicylate and its metabolites in the joint exudates of subjects with chronic arthritis treated with salicylate].
Boll Soc Ital Biol Sper. 1970 Jan 30;46(2):56-8.
10
Control of morning stiffness in rheumatoid arthritis by high salicylate dosage. Preliminary report.高剂量水杨酸盐对类风湿关节炎晨僵的控制。初步报告。
Ann Phys Med. 1967 Feb;9(1):19-21. doi: 10.1093/rheumatology/9.1.19.
Zotero 插件